249 results
Page 9 of 13
8-K
EX-99.1
fi6adiv1g68t6c5t
17 Jan 12
Other Events
12:00am
8-K
EX-99.1
3vate hnj8tpp5
4 Nov 11
Other Events
12:00am
8-K
EX-1.1
u3diy5tfbxl1
30 Mar 11
Rexahn to Raise $10 Million in Registered Direct Offering
12:00am
8-K
EX-10.1
4t01weaw35l1b
30 Mar 11
Rexahn to Raise $10 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
t7qqdnge
30 Mar 11
Rexahn to Raise $10 Million in Registered Direct Offering
12:00am
424B5
8pqtpnirdh043 hc
30 Mar 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
jpvj9pl
7 Mar 11
Rexahn Announces Ceo Transition to Cso and Search for New Ceo
12:00am
8-K
EX-99.1
8bvt l9pu
20 Jan 11
Teva Pharmaceutical Increases Its Investment in Rexahn for the Continued Research and Development of the Pre-clinical Anti-Cancer Compound, RX-3117
12:00am
8-K
EX-99.1
1tml2z l5
13 Sep 10
Rexahn Pharmaceuticals Announces the Appointment of Peter Brandt and Richard Kivel to Board of Directors
12:00am
8-K
EX-10.2
gtskc5k1g 9t1ky3abnb
10 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.3
x2cod9cov6f5byhcft1
10 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
b3et46
10 Sep 10
Departure of Directors or Certain Officers
12:00am